Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Apollo Care, LLC

US Class II Ongoing · initiated 2026-07-29

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Shilpa Medicare Limited

US Class II Ongoing · initiated 2026-07-29

Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials

Shilpa Medicare Limited

US Class II Ongoing · initiated 2026-07-29

Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials

BioSpectra, Inc.

US Class II Ongoing · initiated 2026-07-29

Failed stability specifications

OXYGEN 100%

Canada Type III Ongoing · initiated 2026-07-28

Product quality. Consult your healthcare provider for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any healt…

Regeneron Pharmaceuticals Inc

US Class II Ongoing · initiated 2026-07-28

Lack of Assurance of Sterility

Centric Compounding LLC

US Not Yet Classified Ongoing · initiated 2026-07-27

Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.

Holy Basil Tincture

Canada Type III Ongoing · initiated 2026-07-27

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Baxter Healthcare Corporation

US Class I Ongoing · initiated 2026-07-24

Presence of Particulate Matter

American Regent, Inc.

US Class II Ongoing · initiated 2026-07-24

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

American Regent, Inc.

US Class II Ongoing · initiated 2026-07-24

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

American Regent, Inc.

US Class II Ongoing · initiated 2026-07-24

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

American Regent, Inc.

US Class I Ongoing · initiated 2026-07-24

Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde

American Regent, Inc.

US Class II Ongoing · initiated 2026-07-24

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

American Regent, Inc.

US Class II Ongoing · initiated 2026-07-24

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

American Regent, Inc.

US Class II Ongoing · initiated 2026-07-24

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Mylan Pharmaceuticals Inc

US Class II Ongoing · initiated 2026-07-24

Failed Dissolution Specifications

American Regent, Inc.

US Class II Ongoing · initiated 2026-07-24

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

American Regent, Inc.

US Class II Ongoing · initiated 2026-07-24

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

American Regent, Inc.

US Class II Ongoing · initiated 2026-07-24

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

American Regent, Inc.

US Class II Ongoing · initiated 2026-07-24

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

American Regent, Inc.

US Class II Ongoing · initiated 2026-07-24

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Glenmark Pharmaceuticals Inc., USA

US Class II Ongoing · initiated 2026-07-23

CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.

Aurobindo Pharma USA Inc

US Class II Ongoing · initiated 2026-07-23

shortfill; reports of empty capsules.

MICRO LABS USA INC

US Class II Ongoing · initiated 2026-07-22

Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.